T. Kurosawa

Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study

M. Zálešák, J. Kira, M. Merschhemke, 2021, Multiple sclerosis.

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

Y. Itoyama, J. Kira, S. Kikuchi, 2012, Multiple sclerosis.

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Y. Itoyama, J. Kira, S. Kikuchi, 2014, BMC Neurology.

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study

Y. Itoyama, J. Kira, S. Kikuchi, 2017, BMC Neurology.